28B4 Alexeev, Vitali - Thomas Jefferson University - Thomas Jefferson University
vxa101

Vitali Alexeev, PhD

Contact Dr. Alexeev

233 S. 10th Street
Room 319
Philadelphia, PA 19107

(215) 503-4835

Most Recent Peer-reviewed Publications

  1. The triterpenoid RTA 408 is a robust mitigator of hematopoietic acute radiation syndrome in mice
  2. Radiation protection of the gastrointestinal tract and growth inhibition of prostate cancer xenografts by a single compound
  3. Human adipose-derived stem cell transplantation as a potential therapy for collagen VI-related congenital muscular dystrophy
  4. Chemokine-enhanced DNA vaccination in cancer immunotherapy
  5. Immunotargeting and eradication of orthotopic melanoma using a chemokine-enhanced DNA vaccine
  6. Analysis of chemotactic molecules in bone marrow-derived mesenchymal stem cells and the skin: Ccl27-Ccr10 axis as a basis for targeting to cutaneous tissues
  7. Interleukin 10 in the tumor microenvironment: A target for anticancer immunotherapy
  8. Gene expression signatures of mouse bone marrow-derived mesenchymal stem cells in the cutaneous environment and therapeutic implications for blistering skin disorder
  9. Targeted manipulation of mammalian genomes using designed zinc finger nucleases
  10. Human interleukin 10 receptor 1/IgG1-Fc fusion proteins: Immunoadhesins for human IL-10 with therapeutic potential
  11. Retroviral delivery of ECM genes.
  12. MicroRNA-dependent regulation of cKit in cutaneous melanoma
  13. Site-specific gene modification by oligodeoxynucleotides in mouse bone marrow-derived mesenchymal stem cells
  14. Oligonucleotide-mediated gene targeting in human hepatocytes: Implications of mismatch repair
  15. Protein therapeutics for junctional epidermolysis bullosa: Incorporation of recombinant β3 chain into laminin 332 in β3-/- keratinocytes in vitro
  16. Immunotherapeutic strategies for the treatment of malignant melanoma
  17. Characterization of the CCL21-mediated melanoma-specific immune responses and in situ melanoma eradication
  18. RNAi-mediated silencing of insulin receptor substrate 1 (IRS-1) enhances tamoxifen-induced cell death in MCF-7 breast cancer cells
  19. DNA Pharmaceuticals for Skin Diseases
  20. Distinctive role of the cKit receptor tyrosine kinase signaling in mammalian melanocytes
0